SCHEMBL7085372

SCHEMBL7085372

FC(F)(F)c1cc(-c2cccc3[nH]ccc23)cc(C(F)(F)F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.53
ASH1L Q9NR48 2/20 0.51
CSNK2B P67870 1/20 0.49
CSNK2A1 P68400 1/20 0.49
PIK3CB P42338 3/20 0.47
PIK3CG P48736 1/20 0.46
FTO Q9C0B1 1/20 0.41
AHR P35869 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PARP1 P09874 1/20 0.40
S1PR1 P21453 1/20 0.40
HTR1A P08908 1/20 0.40
HTR7 P34969 1/20 0.40
PIP4K2A P48426 1/20 0.40
PIP4K2B P78356 1/20 0.40
PIP4K2C Q8TBX8 1/20 0.40
CHEK1 O14757 1/20 0.40
HPGDS O60760 1/20 0.39
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31729863 0.90 ASH1L (0.49) PIK3CDASH1LCSNK2BCSNK2A1PIK3CB
SCHEMBL6321122 0.89 ASH1L (0.55) PIK3CDASH1LCSNK2BCSNK2A1PIK3CB
SCHEMBL7090984 0.85 PIK3CD (0.63) PIK3CDASH1LCSNK2BCSNK2A1PIK3CB
SCHEMBL6322590 0.78 PIK3CD (0.57) PIK3CDASH1LCSNK2BCSNK2A1PIK3CB
SCHEMBL10945814 0.77 PIK3CD (0.75) PIK3CDASH1LCSNK2BCSNK2A1PIK3CB
SCHEMBL4795341 0.76 PIP4K2A (0.58) ASH1LPIP4K2APIP4K2BPIP4K2CHPGDS
SCHEMBL15245132 0.75 METAP2 (0.60) PIK3CDASH1LPIK3CBPIM1GSK3B
SCHEMBL27454514 0.75 PIK3CD (0.57) PIK3CDASH1LCSNK2BCSNK2A1PIK3CB
SCHEMBL20540332 0.74 PIK3CD (0.64) PIK3CDASH1LCSNK2BCSNK2A1PIK3CB
SCHEMBL6322388 0.73 ASH1L (0.59) PIK3CDASH1LCSNK2BCSNK2A1PIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203959-A1 Novel modulators of potassium channels 4SC AG (DE) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203959-A1 Novel modulators of potassium channels HCN3, KCNN3, KCNN1 PIK3CD 3331/4885ASH1L 3744/4885CSNK2B 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.